Literature DB >> 15985454

Corticosteroid-regulated genes in rat kidney: mining time series array data.

Richard R Almon1, William Lai, Debra C DuBois, William J Jusko.   

Abstract

Kidney is a major target for adverse effects associated with corticosteroids. A microarray dataset was generated to examine changes in gene expression in rat kidney in response to methylprednisolone. Four control and 48 drug-treated animals were killed at 16 times after drug administration. Kidney RNA was used to query 52 individual Affymetrix chips, generating data for 15,967 different probe sets for each chip. Mining techniques applicable to time series data that identify drug-regulated changes in gene expression were applied. Four sequential filters eliminated probe sets that were not expressed in the tissue, not regulated by drug, or did not meet defined quality control standards. These filters eliminated 14,890 probe sets (94%) from further consideration. Application of judiciously chosen filters is an effective tool for data mining of time series datasets. The remaining data can then be further analyzed by clustering and mathematical modeling. Initial analysis of this filtered dataset identified a group of genes whose pattern of regulation was highly correlated with prototype corticosteroid enhanced genes. Twenty genes in this group, as well as selected genes exhibiting either downregulation or no regulation, were analyzed for 5' GRE half-sites conserved across species. In general, the results support the hypothesis that the existence of conserved DNA binding sites can serve as an important adjunct to purely analytic approaches to clustering genes into groups with common mechanisms of regulation. This dataset, as well as similar datasets on liver and muscle, are available online in a format amenable to further analysis by others.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985454      PMCID: PMC3752664          DOI: 10.1152/ajpendo.00196.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  56 in total

Review 1.  Advances in glucocorticoid therapy.

Authors:  J D Baxter
Journal:  Adv Intern Med       Date:  2000

2.  Conserved noncoding sequences are reliable guides to regulatory elements.

Authors:  R C Hardison
Journal:  Trends Genet       Date:  2000-09       Impact factor: 11.639

3.  Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences.

Authors:  D Yeagley; S Guo; T Unterman; P G Quinn
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

4.  Pharmacogenomic responses of rat liver to methylprednisolone: an approach to mining a rich microarray time series.

Authors:  Richard R Almon; Debra C Dubois; Jin Y Jin; William J Jusko
Journal:  AAPS J       Date:  2005-08-18       Impact factor: 4.009

5.  Burn-induced changes in IGF-I and IGF-binding proteins are partially glucocorticoid dependent.

Authors:  Charles H Lang; Gerald J Nystrom; Robert A Frost
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-01       Impact factor: 3.619

6.  Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis.

Authors:  H Yokoi; A Sugawara; M Mukoyama; K Mori; H Makino; T Suganami; T Nagae; K Yahata; Y Fujinaga; I Tanaka; K Nakao
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

7.  Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy.

Authors:  T Sanai; T Sobka; T Johnson; M el-Essawy; E C Muchaneta-Kubara; O Ben Gharbia; S el Oldroyd; A M Nahas
Journal:  Diabetologia       Date:  2000-01       Impact factor: 10.122

8.  TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.

Authors:  Elizabeth Gore-Hyer; Daniel Shegogue; Malgorzata Markiewicz; Shianlen Lo; Debra Hazen-Martin; Eddie L Greene; Gary Grotendorst; Maria Trojanowska
Journal:  Am J Physiol Renal Physiol       Date:  2002-10

9.  Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.

Authors:  Rohini Ramakrishnan; Debra C DuBois; Richard R Almon; Nancy A Pyszczynski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-02       Impact factor: 2.745

10.  MONKEY: identifying conserved transcription-factor binding sites in multiple alignments using a binding site-specific evolutionary model.

Authors:  Alan M Moses; Derek Y Chiang; Daniel A Pollard; Venky N Iyer; Michael B Eisen
Journal:  Genome Biol       Date:  2004-11-30       Impact factor: 13.583

View more
  27 in total

1.  Application of scaling factors in simultaneous modeling of microarray data from diverse chips.

Authors:  Zhenling Yao; Baiteng Zhao; Eric P Hoffman; Svetlana Ghimbovschi; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2007-02-21       Impact factor: 4.200

2.  Context specific transcription factor prediction.

Authors:  Eric Yang; David Simcha; Richard R Almon; Debra C Dubois; William J Jusko; Ioannis P Androulakis
Journal:  Ann Biomed Eng       Date:  2007-03-22       Impact factor: 3.934

Review 3.  Applications of quantitative pharmacodynamic effect markers in drug target identification and therapy development.

Authors:  Robert M Straubinger; Wojciech Krzyzanski; Crystal M Francoforte; Jun Qu
Journal:  Anticancer Res       Date:  2007 May-Jun       Impact factor: 2.480

4.  Analysis of time-series gene expression data: methods, challenges, and opportunities.

Authors:  I P Androulakis; E Yang; R R Almon
Journal:  Annu Rev Biomed Eng       Date:  2007       Impact factor: 9.590

5.  NETWORKS, BIOLOGY AND SYSTEMS ENGINEERING: A CASE STUDY IN INFLAMMATION.

Authors:  P T Foteinou; E Yang; I P Androulakis
Journal:  Comput Chem Eng       Date:  2009-12-10       Impact factor: 3.845

6.  Modeling autonomic regulation of cardiac function and heart rate variability in human endotoxemia.

Authors:  Jeremy D Scheff; Panteleimon D Mavroudis; Steven E Calvano; Stephen F Lowry; Ioannis P Androulakis
Journal:  Physiol Genomics       Date:  2011-06-14       Impact factor: 3.107

7.  Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.

Authors:  Vivaswath S Ayyar; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2017-07-20       Impact factor: 4.030

8.  Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens.

Authors:  Richard R Almon; Debra C DuBois; Zhenling Yao; Eric P Hoffman; Svetlana Ghimbovschi; William J Jusko
Journal:  Physiol Genomics       Date:  2007-05-01       Impact factor: 3.107

9.  In silico simulation of corticosteroids effect on an NFkB- dependent physicochemical model of systemic inflammation.

Authors:  Panagiota T Foteinou; Steve E Calvano; Stephen F Lowry; Ioannis P Androulakis
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

10.  Pharmacodynamic/pharmacogenomic modeling of insulin resistance genes in rat muscle after methylprednisolone treatment: exploring regulatory signaling cascades.

Authors:  Zhenling Yao; Eric P Hoffman; Svetlana Ghimbovschi; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Gene Regul Syst Bio       Date:  2008-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.